Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The German Lipid Apheresis Registry - remaining to be established.
Schettler V, Jaeger BR, Klingel R; German apheresis working group. Schettler V, et al. Among authors: klingel r. Atheroscler Suppl. 2009 Dec 29;10(5):59-61. doi: 10.1016/S1567-5688(09)71813-6. Atheroscler Suppl. 2009. PMID: 20129377
Rheopheresis for sudden sensorineural hearing loss.
Klingel R, Heibges A, Uygun-Kiehne S, Fassbender C, Mösges R. Klingel R, et al. Atheroscler Suppl. 2009 Dec 29;10(5):102-6. doi: 10.1016/S1567-5688(09)71821-5. Atheroscler Suppl. 2009. PMID: 20129385
Current view: indications for extracorporeal lipid apheresis treatment.
Schettler V, Neumann CL, Hulpke-Wette M, Hagenah GC, Schulz EG, Wieland E; German Apheresis Working Group. Schettler V, et al. Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):15-9. doi: 10.1007/s11789-012-0046-6. Clin Res Cardiol Suppl. 2012. PMID: 22528134 Free PMC article.
Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?
Schettler VJJ, Ringel J, Jacob S, Julius U, Klingel R, Heigl F, Roeseler E, Grützmacher P; German Society of Nephrology (DGfN) and the Foundation of German Centers of Nephrology (DN). Schettler VJJ, et al. Among authors: klingel r. Atheroscler Suppl. 2017 Nov;30:44-49. doi: 10.1016/j.atherosclerosissup.2017.05.005. Epub 2017 Jun 1. Atheroscler Suppl. 2017. PMID: 29096860 Review.
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.
Schettler VJJ, Neumann CL, Peter C, Zimmermann T, Julius U, Hohenstein B, Roeseler E, Heigl F, Grützmacher P, Blume H, Klingel R, Vogt A; Scientific Board of GLAR for the German Apheresis Working Group. Schettler VJJ, et al. Among authors: klingel r. Clin Res Cardiol Suppl. 2019 Apr;14(Suppl 1):33-38. doi: 10.1007/s11789-019-00094-4. Clin Res Cardiol Suppl. 2019. PMID: 30838552
107 results